BDBM765929 (1R,3R)-3-((6- (2,6-dichloro-3- ((5-chloro-2- methoxypyridine)- 3- sulfonamido)phenyl) quinazolin-2- yl)amino)cyclopent- ane-1- carboxamide::US20250263400, Compound 16

SMILES COc1ncc(Cl)cc1S(=O)(=O)Nc1ccc(Cl)c(-c2ccc3nc(N[C@@H]4CC[C@@H](C(N)=O)C4)ncc3c2)c1Cl

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 765929   

TargeteIF-2-alpha kinase GCN2(Human)
Alesta Therapeutics

US Patent
LigandPNGBDBM765929((1R,3R)-3-((6- (2,6-dichloro-3- ((5-chloro-2- meth...)
Affinity DataIC50: 11.7nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent